Sermorelin acetate, Inhibitor

Sermorelin acetate

Cat. Num. AAA5764802

• Purity: 0.98
• Synonyms: Sermorelin acetate; GHRH (1-29); inhibitor

• Purity/Purification: 0.98
• Form/Format: Solid

• Solubility: Water: Insoluble; DMSO: Soluble; (<1mg/ml refers to the product slightly soluble or insoluble)
• SMILES: CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC2=CC=C(C=C2)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N)NC(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](CC3=CC=C(C=C3)O)N.CC(=O)O
• Formula: C151H250N44O44S
• CAS Number: 114466-38-5
• Preparation and Storage: Store at 0-4 degree C for short term (days to weeks), or -20 degree C for long term (months).

Chemical Structure

Related Product Information for Sermorelin acetate, inhibitor

Sermorelin acetate is a growth hormone-releasing hormone (GHRH) analog, is used as a test agent to assess growth hormone (GH) secretion. It is also used as a doping agent in sports due to its correlation with the increased growth of muscular and skeletal tissue.

References

Knoop A, Thomas A, Fichant E,et al. Qualitative identification of growth hormone-releasing hormones in human plasma by means of immunoaffinity purification and LC-HRMS/MS. Anal Bioanal Chem. 2016 May;408(12):3145-53. doi: 10.1007/s00216-016-9377-3. Epub 2016 Feb 15. PubMed PMID: 26879649; PubMed Central PMCID: PMC4830873.
Venhuis BJ, Keizers PH, Klausmann R, Hegger I. Operation resistance: A snapshot of falsified antibiotics and biopharmaceutical injectables in Europe. Drug Test Anal. 2016 Mar;8(3-4):398-401. doi: 10.1002/dta.1888. Epub 2015 Oct 12. PubMed PMID: 26456392.
Thomas A, Walpurgis K, Tretzel L,et al. Expanded test method for peptides >2 kDa employing immunoaffinity purification and LC-HRMS/MS. Drug Test Anal. 2015 Nov-Dec;7(11-12):990-8. doi: 10.1002/dta.1868. Epub 2015 Sep 18. PubMed PMID: 26382721.
Bagno LL, Kanashiro-Takeuchi RM, Suncion VY,et al. Growth hormone-releasing hormone agonists reduce myocardial infarct scar in swine with subacute ischemic cardiomyopathy. J Am Heart Assoc. 2015 Mar 31;4(4). pii: e001464.